Sustainability, affordability, and equity of corporate drug donations: the case of Malarone

被引：14

作者：

Shretta, R

Brugha, R

Robb, A

Snow, RW

机构：

[1] Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Programme, Nairobi, Kenya

[2] London Sch Hyg & Trop Med, Hlth Policy Unit, London WC1, England

[3] WHO, Malaria Unit AFRO, Harare, Zimbabwe

[4] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 9DU, England

来源：

LANCET | 2000年 / 355卷 / 9216期

关键词：

D O I：

10.1016/S0140-6736(00)02251-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1718 / 1720

页数：3

共 16 条

[1]

BATES JA, 1998, OPTIONS PROMOTING FI, P1

[2] Malarone-donation programme in Africa [J].

Bloland, PB ;

Kazembe, PN ;

Watkins, WM ;

Doumbo, OK ;

Nwanyanwu, OC ;

Ruebush, TK .

LANCET, 1997, 350 (9091) :1624-1625

[3]

BRUNDTLAND GH, 1999, WHO WAY AHEAD

[4]

BUSE K, IN PRESS B WHO

[5] Malarone-donation programme [J].

Foege, WH .

LANCET, 1997, 350 (9091) :1628-1629

[6] The "Roll Back Malaria" campaign [J].

Nabarro, DN ;

Tayler, EM .

SCIENCE, 1998, 280 (5372) :2067-2068

[7] Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum:: Genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites [J].

Nzila, AM ;

Mberu, EK ;

Sulo, J ;

Dayo, H ;

Winstanley, PA ;

Sibley, CH ;

Watkins, WM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) :991-996

[8] Atovaquone and proguanil for Plasmodium falciparum malaria [J].

Radloff, PD ;

Philipps, J ;

Nkeyi, M ;

Hutchinson, D ;

Kremsner, PG .

LANCET, 1996, 347 (9014) :1511-1514

[9]

RAPUODA BA, 1998, MALARIA INFECT DIS A, V8, P25

[10]

RIDLEY R, 1999, 3 GLOB FOR HLTH RES

← 1 2 →